Scholarly article on topic 'CME Test'

CME Test Academic research paper on "Clinical medicine"

Share paper
Academic journal
Urological Science
OECD Field of science

Similar topics of scientific paper in Clinical medicine , author of scholarly article —

Academic research paper on topic "CME Test"

Urological Science 24 (2013) I—II


Contents lists available at SciVerse ScienceDirect

Urological Science

journal homepage:

CME Test

Please read this issue of Urological Science and return the postage-paid reply slip with your answers by August 31, 2013. A score of 80% or better will earn three CME credits.

1. A 55-year-old unmarried man with erectile dysfunction presents to the clinic for treatment. His serum testosterone level is 700 ng/mL (normal, 300-1100 ng/mL). The best treatment option is:

A. Sildenafil

B. Testosterone injection

C. Androderm patch

D. Vacuum erection device

Urol Sci 2013;24(2):35-40

2. Sildenafil produces a penile erection by inhibiting what enzyme?

A. Cytochrome 3A4


C. Phosphodiesterase

D. Nitric oxide synthetase

Urol Sci 2013;24(2):35-40

3. When counseling patients on the proper use of sildenafil, which one of the following is correct?

A. Take it once a day in the morning

B. The ideal dose will produce an erection that will last 4 hours

C. If the first dose does not work, take a second dose 30 minutes later

D. Avoid nitrates for 24 hours before or after the last dose of sildenafil

Urol Sci 2013;24(2):35-40

4. Prior to initiating testosterone-replacement therapy for sexual dysfunction, the patient should be screened for this condition as it is a contraindication to using testosterone:

A. Testicular cancer

B. Asthma

C. Myocardial infarction

D. Prostate cancer

Urol Sci 2013;24(2):35-40

Continued on next page

Urol Sci CME Test-Reply Slip

Volume 24 Issue 2

l.( ) 2.( ) 3.( )

4.( ) 5.( ) 6.( )

7.( ) 8. ( ) 9. ( )

Membership no.:_ Name:



1879-5226/$ - see front matter

CME Test / Urological Science 24 (2013) I-II

5. Which medical disease could affect lower urinary tract function during the progression of this disease?

A. Chronic heart failure

B. Constipation

C. Chronic obstructive pulmonary disease

D. Sjogren's syndrome

E. All of the above

Urol Sci 2013;24(2):41 -45

6. Systemic lupus erythematosus (SLE) can cause lupus cystitis and bladder dysfunction in patients. Which description is false?

A. SLE can cause interstitial cystitis-like symptoms and bilateral hydronephrosis with ureterovesical junction stenosis

B. An increase in serum anti-dsDNA is associated with the presence of lupus cystitis

C. The disease activity of SLE measured by SLEDAI is positively associated with the severity of lower urinary tract symptoms

D. Central nervous system involvement in SLE patients is not related to the presence of lower urinary tract symptoms

E. Urodynamic studies of SLE patients with lower urinary tract symptoms may show a small cystometric bladder capacity

Urol Sci 2013;24(2):41 -45

7. Which of the following is not a predisposing factor for acute focal pyelonephritis?

A. Diabetes

B. Immunosuppression

C. Vesicoureteral reflux

D. Renal tumor

Urol Sci 2013;24(2):56-57

8. Which of the following is not an imaging finding of acute focal


A. Poor nephrogram and delayed pelvicalyceal opacification in the involved enlarged kidney on intravenous urography

B. Color Doppler ultrasound shows no blood flow throughout the lesion

C. Contrast-enhanced computed tomography shows solitary or multiple low-attenuation wedge-shaped lesions radiating from the renal hilum to the renal capsule

D. Scintigraphic findings show solitary or multiple wedge-shaped lesions with decreased renal activity

Urol Sci 2013;24(2):56-57

9. Suitable management for acute focal pyelonephritis is:

A. Observation

B. Adequate hydration

C. Adequate hydration, together with suitable and adequate antibiotics administration

D. Surgery

Urol Sci 2013;24(2):56-57

Volume 24 Issue 1


1. (D) 2. (A) 3. (C) 4. (A) 5. (C) 6. (D) 7. (D) 8. (E) 9. (E)